blood cell technologies, LLC

9 shipyard lane
setauket, new york 11733

NYS Entity Status
ACTIVE

NYS Filing Date
JULY 17, 2014

NYS DOS ID#
4608034

County
SUFFOLK

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY

Name History
2014 - BLOOD CELL TECHNOLOGIES, LLC









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • FDA approves 1st gene therapy treatment for cancer
    By Catherine Ho - Wednesday Aug 30, 2017

    The Food and Drug Administration on Wednesday approved the first gene therapy treatment for cancer, green-lighting Novartis Pharmaceuticals’ cell therapy treatment for childhood leukemia. The regulatory approval had been widely expected but came earlier than analysts’ predictions. It signals that other drug companies developing cell-therapy treatments may also be able to commercialize what medical experts say is a revolutionary new form of medicine. The therapy extracts a patient’s cells from his or her blood, sends them to a manufacturing site to genetically modify them, and then re-infuses them into the person’s body to attack cancer cells.

    Source: SFGATE.com: Business and Technology News
  • Health thyself: Skin-zapping chip aims to reprogram cells for tissue repair
    By Beth Mole - Thursday Aug 10, 2017

    With an electrical pulse, skin cells form blood vessels and neurons in early animal work.

    Source: Ars Technica
  • Rubius Adds $120M to Ready Tests of Red Blood Cells as Drug Carriers
    By Frank Vinluan - Wednesday Jun 21, 2017

    The main role of red blood cells is to carry life-sustaining oxygen throughout the body. Rubius Therapeutics believes these cells can carry something more: therapeutic payloads delivered directly to the organs and tissues of patients with severe diseases. Less than two years after launch, Cambridge, MA-based Rubius has reeled in $120 million in funding from […]

    Source: Xconomy VC, Deals, & Startups Feed
  • WD Navarre Holdings Files for Chapter 11 Protection
    Friday Sep 8, 2017

    WD Navarre Holdings LLC, the corporate parent of technology products distributor WYNIT Distribution LLC, filed for bankruptcy protection Friday.

    Source: The Wall Street Journal: Technology: What's News
  • Harvard Biotech Spinout Lands $10M to Make Platelets From Stem Cells
    By Frank Vinluan - Thursday Jun 8, 2017

    If you’ve donated blood, you probably received a follow-up message asking you to consider a platelet donation. Donation centers must constantly replenish their blood supplies, but the need for platelets is particularly acute. Compared to other components of blood, platelets are fragile and short lived, which puts high demand on the small supply of these […]

    Source: Xconomy VC, Deals, & Startups Feed
  • US clears first ‘living drug’ for tough childhood leukemia
    By Associated Press - Wednesday Aug 30, 2017

    WASHINGTON — Opening a new era in cancer care, the Food and Drug Administration on Wednesday approved the first treatment that genetically engineers patients’ own blood cells into an army of assassins to seek and destroy childhood leukemia. The CAR-T cell treatment developed by Novartis and the University of Pennsylvania is the first type of...

    Source: New York Post: News
blood cell technologies llc setauket ny